Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature

Overview of attention for article published in Drug Design, Development and Therapy, July 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 42 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Prolastin-C for the Treatment of Alpha1-Antitrypsin Deficiency: A Review of Economic Evaluations

Cited by Canadian Agency for Drugs and Technologies in Health on 16 May 2019

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Dove Medical Press

Article Metrics